Copy Number Variations

Researchers Develop Mouse Model To Help Find How A Gene Mutation Leads To Autism

Source: 
Medical News Today
Date Published: 
December 20, 2010
Abstract: 

Researchers from Mount Sinai School of Medicine have found that when one copy of the SHANK3 gene in mice is missing, nerve cells do not effectively communicate and do not show cellular properties associated with normal learning. This discovery may explain how mutations affecting SHANK3 may lead to autism spectrum disorders (ASDs). The research is currently published in Molecular Autism.

Inhibitory Neurons Key to Understanding Neuropsychiatric Disorders

Source: 
Science Daily
Date Published: 
November 11, 2010
Abstract: 

In 1999, Baylor College of Medicine researcher Dr. Huda Zoghbi and her colleagues identified mutations in the gene called MECP2 as the culprit in a devastating neurological disorder called Rett syndrome . In new research in mice published in the current issue of the journal Nature, Zoghbi and her colleagues demonstrate that the loss of the protein MeCP2 in a special group of inhibitory nerve cells in the brain reproduces nearly all Rett syndrome features.

New Autism Susceptibilty Genes Identified

Source: 
Medical News Today
Date Published: 
June 10, 2010
Abstract: 

Mount Sinai researchers and the Autism Genome Project Consortium (AGP) announced that they have identified new autism susceptibility genes that may lead to the development of new treatment approaches. These genes, which include SHANK2, SYNGAP1, DLGAP2 and the X-linked DDX53-PTCHD1 locus, primarily belong to synapse-related pathways, while others are involved in cellular proliferation, projection and motility, and intracellular signaling

New Genetic Risk Factor for Both Autism and Schizophrenia

Source: 
Science Daily
Date Published: 
November 4, 2010
Abstract: 

Researchers have uncovered a prominent genetic risk factor for autism spectrum disorders and schizophrenia is a small genomic deletion. Remarkably, they found the same deletion on chromosome 17 in 24 separate patients. This CNV was absent in 52,448 controls, making the finding statistically significant. Someone with this deletion is 13.58 times more likely to develop ASD or schizophrenia than is someone lacking this CNV. This gene mutation is also known to cause kidney disease (renal cysts and diabetes syndrome, RCAD).

Developmental Problems, Some Exist in the Genes

Source: 
Medical News Today
Date Published: 
August 18, 2010
Abstract: 

DNA for each individual contains variants that are more or less common in the overall population.

Some gene variations are actually genetic deletions, where sections of DNA 'code' are missing entirely. These variants are likely to have important effects on gene function and, therefore, likely to contribute to diseases associated with that gene. But what happens when multiple genes are disrupted in a single family?

Disturbances in Certain Genes Play a Role in Autism

Source: 
Medical News Today
Date Published: 
August 17, 2010
Abstract: 

Together with colleagues from an international research group, autism researcher Christopher Gillberg of the University of Gothenburg, Sweden, has found in a new study that autism can be partially explained by abnormalities in certain genes. The group's results could, in the long run, pave the way for more appropriate treatments for autism.

In the article the group reveals that a survey of 1,000 individuals with autism and 1,300 without showed that Copy Number Variants (CNVs) sub-microscopic abnormalities in the chromosomes are heavily over-represented in autistic people.

Functional Impact of Global Rare Copy Number Variation in Autism Spectrum Disorders

Source: 
Nature, Pinto et al
Date Published: 
July 2010
Year Published: 
2010

A genome-wide analysis reveals that people with ASDs carry a higher load of rare copy-number variants — segments of DNA for which the copy number differs between individual genomes — which are either inherited or arise de novo. The results implicate several novel genes as ASD candidates and point to the importance of cellular proliferation, projection and motility as well as specific signalling pathways in this disorder.

Functional impact of global rare copy number variation in autism spectrum disorders

Source: 
Nature
Date Published: 
June 7, 2010
Abstract: 

This study analysed the genome-wide characteristics of rare (<1% frequency) copy number variation in ASD using dense genotyping arrays. When comparing 996 ASD individuals of European ancestry to 1,287 matched controls, cases were found to carry a higher global burden of rare, genic copy number variants (CNVs), especially so for loci previously implicated in either ASD and/or intellectual disability. Among the CNVs there were numerous de novo and inherited events, sometimes in combination in a given family, implicating many novel ASD genes such as SHANK2, SYNGAP1, DLGAP2 and the X-linked DDX53–PTCHD1 locus. We also discovered an enrichment of CNVs disrupting functional gene sets involved in cellular proliferation, projection and motility, and GTPase/Ras signaling. Our results reveal many new genetic and functional targets in ASD that may lead to final connected pathways.

Mutations in the SHANK2 Synaptic Scaffolding Gene in Autism Spectrum

Source: 
Nature Genetics, Berkel et al
Date Published: 
June 2010
Year Published: 
2010

Using microarrays, the department of molecular human genetics in Heidelberg, Germany identified de novo copy number variations in the SHANK2 synaptic scaffolding gene in two unrelated individuals with autism-spectrum disorder (ASD) and mental retardation. DNA sequencing of SHANK2 in 396 individuals with ASD, 184 individuals with mental retardation and 659 unaffected individuals (controls) revealed additional variants that were specific to ASD and mental retardation cases, including a de novo nonsense mutation and seven rare inherited changes. Their findings further link common genes between ASD and intellectual disability.

IntegraGen Announces Publication of Four Genetic Variants in Autism

Source: 
Medical News Today
Date Published: 
May 14, 2010
Abstract: 

IntegraGen SA, a French biotechnology company dedicated to gene discovery, announced today the publication of the results of a collaborative study reporting the use of a combined analysis of multiple genetic variants in a genetic score to help identify individuals at high risk of developing autism.